Hepatocyte Growth Factor/C-Met Signaling in Head and Neck Cancer and Implications for Treatment

Cancers - Switzerland
doi 10.3390/cancers9040039
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

PET of C-Met in Cancer With 64Cu-Labeled Hepatocyte Growth Factor

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2015English

C-Met Proto-Oncogene (MET; HGFR); Hepatocyte Growth Factor/Scatter Factor (HGF/SF)

Science-Business eXchange
2014English

Hepatocyte Growth Factor/C-Met Axis in Thyroid Cancer: From Diagnostic Biomarker to Therapeutic Target

Biomarker Insights
BiochemistryMolecular MedicinePharmacology
2017English

Dual Blockade of EGFR and C-Met Abrogates Redundant Signaling and Proliferation in Head and Neck Carcinoma Cells

Clinical Cancer Research
Cancer ResearchOncology
2011English

Activation of Hepatocyte Growth Factor/Met Signaling Initiates Oncogenic Transformation and Enhances Tumoraggressiveness in the Murine Prostate

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2018English

Down-Regulation of MET, the Receptor for Hepatocyte Growth Factor

Oncogene
Cancer ResearchGeneticsMolecular Biology
2001English

Resistance to Targeted Cancer Drugs Through Hepatocyte Growth Factor Signaling

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2014English

Prereferral Head and Neck Cancer Treatment

Archives of Otolaryngology–Head & Neck Surgery
2010English

Tumorigenicity of the Met Proto-Oncogene and the Gene for Hepatocyte Growth Factor.

Molecular and Cellular Biology
Cell BiologyMolecular Biology
1992English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy